Literature DB >> 29107139

Spatial attributes of the four-helix bundle group of bacteriocins - The high-resolution structure of BacSp222 in solution.

Michał Nowakowski1, Łukasz Jaremko2, Benedykt Wladyka3, Grzegorz Dubin4, Andrzej Ejchart5, Paweł Mak6.   

Abstract

BacSp222 is a multifunctional bacteriocin produced by Staphylococcus pseudintermedius strain 222, an opportunistic pathogen of domestic animals. At micromolar concentrations, BacSp222 kills Gram-positive bacteria and is cytotoxic toward mammalian cells, while at nanomolar doses, it acts as an immunomodulatory factor, enhancing nitric oxide release in macrophage-like cell lines. The bacteriocin is a cationic, N-terminally formylated, 50-amino-acid-long linear peptide that is rich in tryptophan residues. In this study, the solution structure of BacSp222 was determined and compared to the currently known structures of similar bacteriocins. BacSp222 was isolated from a liquid culture medium in a uniformly 13C- and 15N-labeled form, and NMR data were collected. The structure was calculated based on NMR-derived constraints and consists of a rigid and tightly packed globular bundle of four alpha-helices separated by three short turns. Although the amino acid sequence of BacSp222 has no significant similarity to any known peptide or protein, a 3D structure similarity search indicates a close relation to other four-helix bundle-motif bacteriocins, such as aureocin A53, lacticin Q and enterocins 7A/7B. Assuming similar functions, biology, structure and physicochemical properties, we propose to distinguish the four-helix bundle bacteriocins as a new Type A in subclass IId of bacteriocins, containing linear, non-pediocin-like peptides.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BacSp222; Four-helix bundle bacteriocins; Nuclear magnetic resonance

Mesh:

Substances:

Year:  2017        PMID: 29107139     DOI: 10.1016/j.ijbiomac.2017.10.158

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

1.  Bacteriocin BacSp222 and Its Succinylated Forms Exhibit Proinflammatory Activities Toward Innate Immune Cells .

Authors:  Justyna Śmiałek; Monika Bzowska; Alicja Hinz; Renata Mężyk-Kopeć; Kamilla Sołtys; Paweł Mak
Journal:  J Inflamm Res       Date:  2022-08-12

2.  Isolation, characterization, and mode of action of a class III bacteriocin produced by Lactobacillus helveticus 34.9.

Authors:  Iulia-Roxana Angelescu; Silvia-Simona Grosu-Tudor; Lucia-Roxana Cojoc; Gabriel-Mihai Maria; Gabriela N Chirițoiu; Cristian V A Munteanu; Medana Zamfir
Journal:  World J Microbiol Biotechnol       Date:  2022-09-09       Impact factor: 4.253

3.  The fluorescent protein iLOV as a reporter for screening of high-yield production of antimicrobial peptides in Pichia pastoris.

Authors:  Annemette Kjeldsen; Jack E Kay; Scott Baxter; Stephen McColm; Cristina Serrano-Amatriain; Scott Parker; Ellis Robb; S Alison Arnold; Craig Gilmour; Anna Raper; Graeme Robertson; Robert Fleming; Brian O Smith; Ian G Fotheringham; John M Christie; Leonardo Magneschi
Journal:  Microb Biotechnol       Date:  2022-03-21       Impact factor: 6.575

4.  Fast evaluation of protein dynamics from deficient 15N relaxation data.

Authors:  Łukasz Jaremko; Mariusz Jaremko; Andrzej Ejchart; Michał Nowakowski
Journal:  J Biomol NMR       Date:  2018-03-28       Impact factor: 2.835

5.  Structure, Biosynthesis, and Biological Activity of Succinylated Forms of Bacteriocin BacSp222.

Authors:  Justyna Śmiałek; Michał Nowakowski; Monika Bzowska; Oliwia Bocheńska; Agnieszka Wlizło; Andrzej Kozik; Grzegorz Dubin; Paweł Mak
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

6.  New Genus Fibralongavirus in Siphoviridae Phages of Staphylococcus pseudintermedius.

Authors:  Michal Zeman; Pavol Bárdy; Veronika Vrbovská; Pavel Roudnický; Zbyněk Zdráhal; Vladislava Růžičková; Jiří Doškař; Roman Pantůček
Journal:  Viruses       Date:  2019-12-10       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.